Given its dual roles in glycosylation and immune regulation, DDOST represents a promising candidate for future studies in tumor progression and therapeutic resistance, particularly in soft tissue sarcomas where immune modulation and glycosylation dynamics remain underexplored. Here, DDOST is linked to soft tissue sarcoma.